Resultados globales: 1 registros encontrados en 0.02 segundos.
Artículos, Encontrados 1 registros
Artículos Encontrados 1 registros  
1.
9 p, 341.7 KB Risk of requiring a wheelchair in primary progressive multiple sclerosis : Data from the ORATORIO trial and the MSBase registry / Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Butzkueven, Helmut (Monash University) ; Spelman, Tim (University of Melbourne) ; Horakova, Dana (Charles University. Faculty of Medicine in Hradec Králové) ; Hughes, Stella (Craigavon Area Hospital) ; Solaro, Claudio Marcello (CRRF "Mons. Luigi Novarese") ; Izquierdo, Guillermo (Hospital Vithas Nisa) ; Kubala Havrdova, Eva (Charles University) ; Grand'Maison, Francois (Neuro Rive-Sud) ; Prat, Alexandre (Universite de Montreal) ; Girard, Marc (Universite de Montreal) ; Hupperts, Raymond (Zuyderland Ziekenhuis) ; Onofrj, Marco (University G. d'Annunzio) ; Lugaresi, Alessandra (UOSI Riabilitazione Sclerosi Multipla) ; Taylor, Bruce (Royal Hobart Hospital) ; Giovannoni, Gavin (Queen Mary University of London) ; Kappos, Ludwig (University of Basel) ; Hauser, Stephen L. (University of California) ; Craveiro, Licinio (F. Hoffmann-La Roche Ltd) ; Freitas, Rita (F. Hoffmann-La Roche Ltd) ; Model, Fabian (F. Hoffmann-La Roche Ltd) ; Overell, James (F. Hoffmann-La Roche Ltd) ; Muros-Le Rouzic, Erwan (F. Hoffmann-La Roche Ltd) ; Sauter, Annette (F. Hoffmann-La Roche Ltd) ; Wang, Qing (F. Hoffmann-La Roche Ltd) ; Wormser, David (F. Hoffmann-La Roche Ltd) ; Wolinsky, Jerry S. (McGovern Medical School) ; MSBase Study Group ; Universitat Autònoma de Barcelona
Background and purpose: Reaching Expanded Disability Status Scale (EDSS) ≥7. 0 represents the requirement for a wheelchair. Here we (i) assess the effect of ocrelizumab on time to EDSS ≥7. 0 over the ORATORIO (NCT01194570) double-blind and extended controlled periods (DBP+ECP), (ii) quantify likely long-term benefits by extrapolating results, and (iii) assess the plausibility of extrapolations using an independent real-world cohort (MSBase registry; ACTRN12605000455662). [...]
2022 - 10.1111/ene.14824
European Journal of Neurology, Vol. 29 Núm. 4 (2022) , p. 1082-1090  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.